Interference Peak [Bioanalytics]

posted by Dr. Harish L. Rao – India, 2007-09-20 11:42 (6445 d 11:42 ago) – Posting: # 1096
Views: 5,830

(edited on 2007-09-20 11:56)

Dear Group Members,

During subject plasma sample analysis by LC/MS/MS, an extra peak (possibly due to metabolite) is observed which is not completely separated from the drug peak. But Method Validation was performed without the metabolite (as per OGD communication) & there was no interference peak during method validation. In such a situation, how should the analyst proceed with subject sample analysis?

Thanks & regards,
Dr. Harish L. Rao

Complete thread:

UA Flag
Activity
 Admin contact
23,424 posts in 4,927 threads, 1,670 registered users;
202 visitors (0 registered, 202 guests [including 9 identified bots]).
Forum time: 23:25 CEST (Europe/Vienna)

No matter what side of the argument you are on,
you always find people on your side
that you wish were on the other.    Thomas Berger

The Bioequivalence and Bioavailability Forum is hosted by
BEBAC Ing. Helmut Schütz
HTML5